Huang Wei, Zhang Yan, Shen Bai-Hua, Wang Shuo, Meng Hong-Zhou, Jin Xiao-Dong
Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China,
Cancer Manag Res. 2019 Jan 18;11:899-907. doi: 10.2147/CMAR.S189893. eCollection 2019.
To compare the outcomes of health-related quality of life (HRQOL) in patients undergoing open (ORP), laparoscopic (LRP), or robot-assisted (RARP) radical prostatectomy.
We retrospectively analyzed 347 men with clinically localized prostate cancer treated with ORP (n=97), LRP (n=71), or RARP (n=179) by high-volume surgeons in our institution between January 2014 and December 2016. The primary endpoint was HRQOL including urinary incontinence and erectile dysfunction.
One year after surgery, 15.9% of men reported moderate to severe urinary incontinence (ORP 16.5%, LRP 15.4%, and RARP 15.7%), with only 4.6% using pads. There were no statistically significant differences in the ratios of no pad usage and urinary incontinence bother after 12 months postoperatively among the three groups. However, 67.7% of the men reported moderate to severe erectile dysfunction (ORP 66%, LRP 66.1%, and RARP 69.3%) 12 months after surgery. There was no statistically significant difference in the international index of erectile function-5 (IIEF-5) postoperatively among the different surgical groups. In the univariate and multivariate analyses, age at surgery, preoperative IIEF-5, and neurovascular bundle preservation were the risk factors for moderate to severe sexual bother. Interestingly, 16.1% of men with an erection hardness score of grade 3-4 were hesitant to become sexually active postoperatively.
ORP, LRP, and RARP have similar early HRQOL outcomes with respect to urinary incontinence and erectile dysfunction. In contrast to urinary continence, erectile dysfunction is still a serious concern for patients who undergo radical prostatectomy.
比较接受开放性根治性前列腺切除术(ORP)、腹腔镜根治性前列腺切除术(LRP)或机器人辅助根治性前列腺切除术(RARP)的患者的健康相关生活质量(HRQOL)结局。
我们回顾性分析了2014年1月至2016年12月期间在我们机构由经验丰富的外科医生对347例临床局限性前列腺癌男性患者进行的治疗,其中接受ORP(n = 97)、LRP(n = 71)或RARP(n = 179)。主要终点是HRQOL,包括尿失禁和勃起功能障碍。
术后1年,15.9%的男性报告有中度至重度尿失禁(ORP为16.5%,LRP为15.4%,RARP为15.7%),仅4.6%使用尿垫。三组术后12个月不使用尿垫的比例和尿失禁困扰比例无统计学显著差异。然而,术后12个月,67.7%的男性报告有中度至重度勃起功能障碍(ORP为66%,LRP为66.1%,RARP为69.3%)。不同手术组术后勃起功能国际指数-5(IIEF-5)无统计学显著差异。在单因素和多因素分析中,手术年龄、术前IIEF-5和神经血管束保留是中度至重度性困扰的危险因素。有趣的是,勃起硬度评分为3-4级的男性中有16.1%术后对恢复性活动犹豫不决。
ORP、LRP和RARP在尿失禁和勃起功能障碍方面具有相似的早期HRQOL结局。与尿失禁不同,勃起功能障碍仍然是接受根治性前列腺切除术患者的一个严重问题。